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CytotoxicityAbstract The evaluation of the leishmanicidal and trypanocidal activity of the hydroalcoholic
extract of the bark of Stryphnodendron rotundifolium Mart. (EHCSR) was carried out to ﬁnd an
alternative treatment for parasitic diseases. EHCSR was prepared and used at four different con-
centrations (1000, 500, 250, 125 lg/mL) in in vitro assays for activity against Leishmania promastig-
otes using the species Leishmania brasiliensis and Leishmania infantum and for trypanocidal activity
using the epimastigotes of Trypanosoma cruzi. We also tested EHCSR for cytotoxicity against
adhered cultured Murine J774 ﬁbroblasts. The tests were performed in triplicate, and the percent
mortality of parasites, IC50 and percent toxicity were determined. With regard to anti-leishmania
activity against L. infantum, there was a mean mortality of 45% at all concentrations, and againstl activity
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of Stryphnodendron rotundifolium Mart. SauL. brasiliensis, a substantial effect was seen at 1000 lg/mL with 56.38% mortality, where the IC50
values were 1338.76 and 987.35 lg/mL, respectively. Trypanocidal activity was notably high at
1000 lg/mL extract with 82.31% mortality of epimastigotes. Cytotoxicity at the highest extract con-
centrations of 500 and 1000 lg/mL was respectively 75.12% and 94.14%, with IC50 = 190.24 lg/
mL. Despite that the extract has anti-parasitic activity, its substantial cytotoxicity against ﬁbrob-
lasts cells makes its systemic use nonviable as a therapeutic alternative.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Leishmaniasis and Chagas disease are known as serious public
health problems due to their high mortality rate in countries
such as Brazil, since they are directly linked to socioeconomic
issues (Lindoso and Lindoso, 2009).
Leishmaniasis is caused by a blood parasite, where its trans-
mission is through the bite of an infected sandﬂy, where during
blood feeding, parasites are inoculated into the skin of the host.
Domestic animals serve as reservoirs, especially the house dog
and wild ones, but humans have become a possible reservoir
due to the organizational changes in cities, and thus, leishmania-
sis is no longer just a rural disease (Monteiro et al., 2005).
American cutaneous leishmaniasis has 3 clinical forms, cuta-
neous, mucocutaneous and diffuse cutaneous. The mucocuta-
neous one is characterized by lesions that destroy cartilage
andmucosal tissues. Visceral leishmaniasis, known as kala azar,
is considered the most severe and has symptoms such as hep-
atosplenomegaly and pancytopenia, and can lead to death
depending on the progress of the disease. These 3 forms are
caused respectively by Leishmania brasiliensis and Leishmania
donovani, Leishmania infantum and Leishmania chagasi
(Aleixo et al., 2006; Maia-Elkhoury et al., 2008).
A major problem with this disease is the lack of vaccines
and medicines that are safe and effective, especially for dogs,
which have become the main host and cause of major difﬁcul-
ties in controlling the disease, because this animal is found in
homes and because they are cherished by humans (Monteiro
et al., 2005).
Chagas disease is caused by the protozoan Trypanosoma
cruzi, which is transmitted by the triatomine known as the kiss-
ing bug, during blood feeding, when it penetrates the skin leav-
ing urine or feces infected with metacyclic trypomastigotes,
which infect the host, usually mammals. But this is not the
only transmission route, as others have been demonstrated,
such as contamination by blood transfusion and organ trans-
plantation and orally by ingestion of the vector, which hap-
pens when it is triturated during the preparation of any food
(Schoﬁeld et al., 2006). The symptomatology is diverse, with
the most serious problems in the chronic phase with the occur-
rence of cardiac and hepatic complications, among others
(Rassi et al., 2010). The treatment of the latter has several lim-
itations, such as being more effective in the acute phase of the
disease and causing many side effects (Coura, 2009). Because
of these factors, the importance of developing new drugs is evi-
dent, especially those derived from medicinal plants, due to
their wide variety and easy access for people with less purchas-
ing power (Izumi et al., 2011).
Because of the tradition of using medicinal plants in Brazil,
their pharmacological properties have been arduouslyV.C.S. et al., The use of herbs against n
di Journal of Biological Sciences (2015)explored by Brazilian investigators and more recently by the
pharmaceutical industry because of the need to develop new
drugs (de Oliveira et al., 2014).
The genus Stryphnodendron belongs to the subfamily
Mimosoideae and family Leguminosae, which encompasses
approximately 64 genera. Stryphnodendron rotundifolium
Mart is species popularly known as ‘barbatima˜o, barba-de-
tima˜o, chara˜ozinho-roxo, casca-da-virgindade, casca-da-moci-
dade and barbatima˜o-vermelho’’ (Sanches et al., 2007). The
species S. rotundifolium Mart., endemic to Chapada do
Araripe, is used by much of the population of the Cariri where
the bark of this tree is used to treat wounds, sores, gastritis,
vaginal inﬂammation and infections (Oliveira et al., 2011).
Phytochemical prospecting of S. rotundifolium bark extract
has been performed, showing the presence of tannin pyrogal-
lics, ﬂavones, ﬂavonols, ﬂavononols, xanthones, chalcones, ﬂa-
vonones and steroids as secondary metabolites in this species
(Oliveira et al., 2011), along with antibacterial and antifungal
(Rodrigues et al., 2008), antioxidant (Costa et al., 2012) and
antibiotic-modifying (Oliveira et al., 2011) activity.
Accordingly, the aim of the study was to evaluate the try-
panocidal and leishmanicidal activity of the hydroalcoholic
extract of the bark of S. rotundifolium to determine its thera-
peutic potential in these conditions, for a possible alternative
treatment for patients.
2. Materials and methods
2.1. Botanical material
The plant material of S. rotundifolium was collected in Crato,
Ceara´, Brazil, in March 2011. A voucher specimen of the spe-
cies is deposited in the Herbarium Da´rdaro de Andrade Lima-
URCA under No. 4661.2.2. Preparation of hydroalcoholic extract of the bark of S.
rotundifolium Mart. (EHCSR)
The plant material (dry bark of S. rotundifolium) was subjected
to cold extraction with water and 99.99% ethanol (1:1), and
the solvent was removed using a rotary evaporator, resulting
in a dry crude extract after lyophilization (EHCSR).
2.3. Preparation of the solution EHCSR
EHCSR was dissolved in phosphate buffered saline (PBS, pH
7.2) at a concentration of 1 mg/mL, subsequently giving test
concentrations of 500, 250 and 125 lg/mL. The assays were
performed in triplicate.eglected diseases: Evaluation of in vitro leishmanicidal and trypanocidal activity
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All chemical agents were of analytical grade. Methanol, acetic
acid, gallic acid and caffeic acid were purchased from Merck
(Darmstadt, Germany). Catechin, rutin and kaempferol were
acquired from Sigma Chemical Co. (St. Louis, MO, USA).
High performance liquid chromatography (HPLC-DAD) was
performed with the Shimadzu HPLC system (Shimadzu,
Kyoto, Japan) and Prominence Auto Sampler (SIL-20A),
equipped with Shimadzu LC-20AT reciprocating pumps con-
nected to the degasser DGU 20A5 with integrator CBM
20A, UV–vis detector DAD (diode) SPD-M20A and
Software LC solution 1.22 SP1.
Reverse-phase chromatographic analyses were carried out
under gradient conditions using a C18 column
(4.6 mm · 250 mm) packed with 5-lm diameter particles; the
mobile phase was water containing 2% acetic acid (A) and
methanol (B), and the composition gradient was: 5% of B until
2 min and changed to 25, 40, 50, 60, 70 and 100% B at 10, 20,
30, 40, 50 and 80 min, respectively, following the method
described by da Silva et al. (2014) with slight modiﬁcations.
EHCSR was dissolved in ethanol at a concentration of 5 mg/
mL and analyzed. The presence of ﬁve phenolic compounds
was determined, namely catechin, gallic and caffeic acids and
the ﬂavonoids rutin and kaempferol. Identiﬁcation of these
compounds was performed by comparing their retention time
and UV absorption spectrum with those of commercial stan-
dards. The ﬂow rate was 0.6 mL/min and injection volume
40 lL, and the wavelengths used for detection were 257 nm
for gallic acid, 280 nm for catechin, 325 nm for caffeic acid
and 365 nm for rutin and kaempferol. All samples and mobile
phase were ﬁltered through a 0.45-lm membrane ﬁlter
(Millipore) and then degassed with an ultrasonic bath prior
to use. Stock solutions of reference standards were prepared
in the HPLC mobile phase at concentrations of 0.020–
0.200 mg/mL for kaempferol and rutin and 0.030–0.250 mg/
mL for catechin, caffeic and chlorogenic acids. The chromato-
graphic peaks were conﬁrmed by comparing their retention
times with those of reference standards and by DAD spectra
(200–400 nm). The calibration curves were: gallic acid, Y=
12575x+ 1253.8 (r= 0.9999); caffeic acid, Y= 11407x+
1359.8 (r= 0.9996); catechin, Y= 11355x  1047.1
(r= 0.9968); rutin, Y= 12492x  1065.7 (r= 0.9997); and
kaempferol, Y= 14923x  1238.9 (r= 0.9997).
2.5. Obtaining parasites and cells
We used blood cultures of T. cruzi epimastigotes and pro-
mastigotes of L. brasiliensis and L. infantum. The epimastig-
otes were obtained in the exponential growth phase in liver
infusion tryptose (LIT) and washed twice in sterile PBS, pH
7.2, with centrifugation at 1500 rpm for 10 min at 4 C, and
the number of parasites was determined in a Neubauer cham-
ber. Afterward, the parasites were suspended in LIT medium
supplemented with 10% fetal bovine serum (FBS) (inactivated
at 56 C), adjusted to 5 · 106 epimastigotes/mL, and kept at
4 C until use.
The promastigotes of L. brasiliensis and L. infantum were in
the exponential growth phase in Schneider medium supple-
mented with 5% FBS and 2% urine. They were washed twice
in sterile PBS, pH 7.2, with centrifugation at 1500 rpm forPlease cite this article in press as: Vandesmet, V.C.S. et al., The use of herbs against n
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in a Neubauer chamber. The parasites were then suspended
in Schneider medium plus 5% FCS and 2% of urine, adjusted
to 5 · 106 promastigotes/mL, and kept at 4 C until use.
Fibroblasts were grown in minimal essential medium
(MEM), supplemented with 10% heat-inactivated FBS, peni-
cillin G (100 U/mL) and streptomycin (100 lg/mL). Cultures
were maintained at 37 C in a humidiﬁed 5% CO2 atmosphere
until use.
2.6. In vitro leishmanicidal evaluation
For the evaluation of leishmanicidal activity against the pro-
mastigote form, assays were performed in triplicate in 96-well
culture plates containing 20 lL of EHCSR at concentrations in
descending order, diluted in sterile PBS, pH 7.2, plus 180 lL of
the suspension of promastigotes. In the controls, the parasites
were incubated in the absence of extract or in the presence of
100 lg/mL pentamidine. After the addition of the natural
products, the samples were shaken and incubated at 24 C
for 72 h. The plates were then evaluated visually under a
microscope to check for motility of parasites. The results were
expressed as a percentage. The assays were carried out in tripli-
cate with the objective of assessing the stability of EHCSR
activity and the reproducibility of the results. Pentamidine
was used as the reference drug.
2.7. In vitro evaluation of trypanocidal
The trypanocidal assays against epimastigotes were performed
in triplicate in 96-well culture plates containing 20 lL of
EHCSR at concentrations in descending order, diluted in ster-
ile PBS, pH 7.2, plus 180 lL of epimastigote suspension. In the
control, the parasites were incubated in the absence of extract
or in the presence of 100 lg/L Nifurtimox. The plates were
then shaken and incubated at 24 C for 72 h and assessed
visually under a microscope to check for motility of parasites.
The activity was determined by counting in a Neubauer cham-
ber, followed by statistical evaluation. The results were
expressed as a percentage. The assays were carried out in tripli-
cate to assess the stability of the extract activity and repro-
ducibility of the results.
2.8. Evaluation of cytotoxicity
Murine J477 ﬁbroblasts were adhered to 96-well microdilution
plates at a ﬁnal concentration of 3 · 104 cells/well and incu-
bated at 37 C in an atmosphere of 5% CO2. Subsequently,
MEM was removed and 200 lL of EHCSR in different con-
centrations were added and the plates incubated for another
24 h. Afterward, 20 lL of 2 mM resazurin was added to each
well. Plates were incubated for 3 h and the reduction of resa-
zurin was determined by absorbance at 490 and 595 nm. The
value of the control (blank) was subtracted. Each concentra-
tion was tested in triplicate.
2.9. Statistical analysis
All assays were performed in triplicate and repeated at least
once. Half-maximal growth inhibitory concentration (IC50)eglected diseases: Evaluation of in vitro leishmanicidal and trypanocidal activity
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Table 1 Results of pentamidine on Leishmania infantum
promastigotes in the parasitic form (IC50 = 5.69 lg/mL).
Concentration
(lg/mL)
% Anti-promastigote
(L. infantum)
% ± standard
deviation
100 93.9 0.3
50 93.9 0.1
25 89.2 0.6
12.5 80.6 0.2
6.25 54.2 0.3
3.125 15.5 1.1
Table 2 Results of EHCSR, on Leishmania infantum pro-
mastigotes in the parasitic form (IC50 = 1338.76 lg/mL).
Concentration
(lg/mL)
% Anti-promastigote
(L. infantum)
% ± standard
deviation
1000 47.14 0.69
500 45.63 2.52
250 40.67 1.12
150 43.47 2.72
Table 3 Result of EHCSR, on Leishmania brasiliensis in
parasitic promastigote form (IC50 = 987.35 lg/mL).
Concentration
(lg/mL)
% Anti-promastigote
(L. infantum)
% ± standard
deviation
1000 56.38 5.49
500 4.68 2.06
250 2.85 1.79
150 2.85 1.07
4 V.C.S. Vandesmet et al.was determined by linear regression using GraphPad Prism
Software.
3. Results and discussion
HPLC ﬁngerprinting of EHCSR revealed the presence of gallic
acid (tR = 17.01 min; peak 1), catechin (tR = 24.88 min; peak
2), caffeic acid (tR = 31.62 min; peak 3), rutin
(tR = 47.14 min; peak 4) and kaempferol (tR = 58.49 min;
peak 5) (Fig. 1). Thus, HPLC analysis revealed the EHCSR
contained ﬂavonoids (rutin and kaempferol), phenolics acids
(caffeic acids) and catechin.
An ethnopharmacological study has shown that S. rotundi-
folium is used as a popular medicine by traditional com-
munities in Northeast Brazil. The stem bark of this plant is
used especially in the form of a decoction (de Oliveira et al.,
2014). Phytochemical prospecting of hydroalcoholic extract
of S. rotundifolium (HESR) has led to the identiﬁcation of tan-
nins, pyrogallics, ﬂavones, ﬂavonoids, ﬂavononols, xanthones,
chalcones, ﬂavonones and steroids (Oliveira et al., 2011). Data
from the literature show that bark extracts of species of this
genus contain tannins and ﬂavonoids (Lopes et al., 2009;
Siqueira et al., 2012).
The results in Table 1 show the effect of the reference drug,
pentamidine, on Leishmania sp., where IC50 = 5.69 lg/mL.
Tables 2 and 3 show the results for the anti-promastigote activ-
ity against Leishmania sp. Against L. infantum (Table 2), the
four concentrations of EHCSR tested caused a similar percent-
age of parasite inhibition, around 45%, with an estimated
IC50 = 1300 lg/mL. L. brasiliensis (Table 3) was substantially
inhibited only at 1000 lg/mL, where the percentage of the inhi-
bition was 56.38%, yielding an IC50 = 987.35 lg/mL.
According to Rosas et al. (2007), when more than 50%
parasite inhibition is achieved at an extract concentration of
500 lg/mL, the test substance is considered a good inhibitor
of parasites. Although EHCSR did not show this level of activ-
ity, its potential cannot be ruled out, since its activity came
close to the above benchmark, which can be explained by
the EHCSR components present, including tannins, ﬂavonoids
and phenolic compounds, the main secondary metabolites pre-
sent in this species (Vilar et al., 2010).
The anti-Leishmania effect was the target of a study by
Kolodziej and Kiderlen (2005), who demonstrated that con-
densed tannins, polyphenols, simple phenolics and tanninsFigure 1 Representative high performance liquid chromatograp
Stryphnodendron rotundifolium extract, detection UV was at 325 nm.
three determinations. Averages followed by different letters differ by
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activity of extracts of the fruit of Cocos nucifera L., rich in
polyphenols was evaluated, where a satisfactory effect was
obtained with a minimum inhibitory concentration of 10 lg/
mL (Mendonc¸a-Filho et al., 2004).
According to Paula-Junior et al. (2006), the hydroethanolic
extract of Caryocar brasiliense leaves has antileishmanial activ-
ity against the promastigote forms and strong antioxidantCompounds
mg/g Percent
Gallic acid (peak 1) 209.2±0.07a 20.9
Catechin (peak 2) 175.3±0.02b 17.5
Caffeic acid (peak 3) 64.2±0.05c 6.4
Rutin (peak 4) 118.2±0.01d 11.8
Kaempferol (peak 5) 23.6±0.09e 2.3
hy proﬁle of phenolics and ﬂavonoid composition of the
Results were expressed as mean ± standard deviations (SD) of
Tukey test at p< 0.005.
eglected diseases: Evaluation of in vitro leishmanicidal and trypanocidal activity
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Table 6 EHCSR cytotoxic activity on ﬁbroblasts
(IC50 = 190.24 lg/mL).
Concentration
(lg/mL)
% Cytotoxicity %± standard
deviation
1000 94.14 1.04
500 75.12 1.63
250 62.42 1.01
150 43.39 2.03
Leishmanicidal and trypanocidal activity of Stryphnodendron rotundifolium Mart 5activity, corroborating the ﬁndings of the present study,
because extracts of the genus Stryphnodendron have antioxi-
dant activity as already mentioned (Lopes et al., 2005), and
this was also shown for S. rotundifolium by Costa et al.
(2012). Williams et al. (2003) reported that antioxidant com-
pounds such as ﬂavonoids may have an effect on promastig-
otes of Leishmania sp., where viability was measured by
reduction of a tetrazolium salt. Sen et al. (2008) reported that
treatment with the ﬂavonoid quercetin combined with serum
albumin showed increased bioavailability of the ﬂavonoid,
proving to be major advantage in promoting its effectiveness
against L. donovani.
According to Bezerra et al. (2006) crude extracts from
plants have a greater leishmanicidal effect against promastig-
otes, Reis et al. (2013) showed that the hydroalcoholic extract
of Chenopodium ambrosioides leads to a decrease in parasite
load in infection with L. amazonian in vivo, demonstrating that
the extract used in our study possibly possesses these leish-
manicidal characteristics due to these factors, and because this
is a crude hydroalcoholic extract, as previously used.
Table 4 shows the effect of the reference drug chosen,
Nifurtimox, on motility of T. cruzi. epimastigotes, showing
an IC50 = 2.20 lg/mL. The trypanocidal activity of EHCSR
against epimastigotes (Table 5) showed relevancy at a concen-
tration of 1000 lg/mL, at which there was 82.31% death of
parasitic forms. Lower extract concentrations of 250 and
500 lg/mL showed low toxicity, respectively 2.31% and
7.07%, while the lowest concentration of 150 lg/mL had no
effect on epimastigotes, and IC50 = 748.97 lg/mL was deter-
mined. In studies by Herzog-Soares et al. (2002) using the
crude extract of the bark of the species Stryphnodendron
adstringens, which belongs to the same genus of the extract
used in this study proved to be effective against the parasite
T. Cruzi in vivo, almost totally eliminating all parasites foundTable 5 Result of EHCSR, against Trypanosoma cruzi
epimastigote form in the parasite (IC50 = 748.97 lg/mL).
Concentration
(lg/mL)
% Anti-epimastigote
(T. cruzi)
%± standard
deviation
1000 82.31 12.57
500 7.07 12.55
250 2.13 1.21
150 0 12.35
Table 4 Result of Nifurtimox, on Trypanosoma cruzi epi-
mastigote form in the parasite (IC50 = 20.02 lg/mL).
Concentration
(lg/mL)
% Anti-epimastigote
(T. cruzi)
%± standard
deviation
100 100 00.46
50 93 0.66
10 84 0.62
1 43 0.93
0.5 13 2.50
0.1 0 1.54
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it.
Ribeiro et al. (1997) isolated ﬂavanones from Trixis vau-
thieri L. and found that they eliminated about 99% of the
parasites in infected blood. Grael et al. (2005) isolated a num-
ber of substances from Lychnophora pohlii, where ﬂavonoids
showed considerable trypanocidal activity. Takeara et al.
(2003) demonstrated that ﬂavonoids present in other species
of Lychnophora were effective against T. cruzi in contaminated
blood in blood banks. Schinor et al. (2004) observed the same
activity but in vivo. These data are of paramount importance
for the present study because of the presence of ﬂavonoids in
EHCSR, which shows one of the probable reasons for the try-
panocidal effect observed. Abe et al. (2004) showed that a xan-
thone isolated from Garcinia subellı´ptica was active against
epimastigote and trypomastigote forms and protozoa of T.
cruzi; xanthones were also found in EHCSR.
Previous ﬁndings support the potential anti-parasitic activ-
ity of EHCSR, but one cannot dismiss the importance of the
results demonstrating potential host cytotoxicity (Table 6).
Concentrations of 500 and 1000 lg/mL, which were the most
representative of anti-parasitic activity, also showed very high
toxicity in cultured ﬁbroblasts cells, 75.12% and 94.14%
respectively, with an IC50 = 190.24 lg/mL.
Our results demonstrated a dose-dependent effect, but lim-
ited because bioavailability was not considered. Several studies
have shown the contribution of in vitro assays for in vivo
applicability (Henning et al., 2005). These methods will there-
fore be highly useful for future preclinical and clinical studies.
These results then provide important knowledge to explore the
potential of EHCSR in the treatment of parasitic infections as
T. cruz or Leishmania.
4. Conclusion
We found that the hydroalcoholic extract of S. rotundifolium
bark (EHCSR) had better activity against T. cruzi in compar-
ison with two Leishmania species. However, the results did not
show clinical signiﬁcance with regard to anti-parasitic activity.
EHCSR showed a signiﬁcant cytotoxicity against ﬁbroblast
cells, indicating limits to its use in a systemic way. This plant
appears to be promising for the development of herbal prod-
ucts and/or new drugs with antiparasitary actions, but,
in vivo assay is necessary for drug evaluation.
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